This Month in Psychopharmacology

FDA Approves First Over-the-Counter Naloxone Nasal Spray

The U.S. Food and Drug Administration approved naloxone hydrochlori...

Read More

High-Risk Youth Population Are Not Receiving Behavioral Health Services

Literature on pediatric mental health has suggested that adverse ch...

Read More

Clozapine to Reduce Aggression in Patients With Schizophrenia and Conduct Disorder

The first head-to-head comparison study of clozapine, olanzapine, a...

Read More

2020 NEI Max! Highlight: FBI Profiling of Serial Killers

In this incredible presentation, Dr. Charles Scott fascinated the N...

Read More